Multi-modality imaging for accurate diagnosis of lipomatous hypertrophy of interatrial septum in a patient with lung cancer and increased FDG uptake on PET
- 1Department of Internal Medicine, Community Regional Medical Center, Fresno, California, USA
- 2Division of Cardiology, Community Regional Medical Center, Fresno, California, USA
- Correspondence to Dr Abhishek Chandrakant Sawant,
A 66-year-old female with squamous cell carcinoma of lung underwent positron emission tomography (PET) scan for staging when increased fluorodeoxyglucose (FDG) uptake was noted in between the atrial septum concerning for possible metastasis (figure 1). CT chest revealed an interatrial mass where the Hounsfield density numbers were −50 to −80 HU’s and consistent with a fatty tumour (figure 2) without obliteration of fossa ovalis or tumour invasion via pulmonary veins to suggest a malignancy. A transoesophageal echocardiography (TEE) was performed which revealed a 3.3×3.1 cm echo lucent mass markedly increasing the thickness of the atrial septum with sparing of the fossa ovalis and creating a ‘dumbbell’ appearance in the superior part of the interatrial septum (figure 3), consistent with lipomatous hypertrophy of interatrial septum (LHIS). LHIS has been shown to cause EKG changes, atrial arrhythmias, recurrent pericardial effusions and rarely sudden cardiac death.1 The increased FDG uptake on PET scan is believed to occur due to presence of brown fat in LHIS,2 resulting in a false interpretation of malignancy particularly with coexistent primary lung carcinoma. The specific CT appearance of fat in combination with the characteristic thickening of the atrial septum on TEE helped confirm the diagnosis.3 Thus in this case multi-modality imaging techniques were required to confirm the diagnosis of LHIS, prevent misdiagnosis of cancer recurrence and avoid unnecessary invasive procedures.
Multi-modality imaging including CT scan and TEE helped in diagnosing LHIS, which is a benign adipose tumour of the heart.
Awareness of LHIS as a possible cause for focal atrial FDG uptake (due to presence of brown fat) is important for healthcare providers to prevent misdiagnosis and avoid invasive testing and/or treatment with chemotherapy and radiation.